Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine
- PMID: 20421480
- PMCID: PMC2889329
- DOI: 10.1073/pnas.0914121107
Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine
Abstract
Cholera and enterotoxigenic Escherichia coli (ETEC) are among the most common causes of acute infantile gastroenteritis globally. We previously developed a rice-based vaccine that expressed cholera toxin B subunit (MucoRice-CTB) and had the advantages of being cold chain-free and providing protection against cholera toxin (CT)-induced diarrhea. To advance the development of MucoRice-CTB for human clinical application, we investigated whether the CTB-specific secretory IgA (SIgA) induced by MucoRice-CTB gives longstanding protection against diarrhea induced by Vibrio cholerae and heat-labile enterotoxin (LT)-producing ETEC (LT-ETEC) in mice. Oral immunization with MucoRice-CTB stored at room temperature for more than 3 y provided effective SIgA-mediated protection against CT- or LT-induced diarrhea, but the protection was impaired in polymeric Ig receptor-deficient mice lacking SIgA. The vaccine gave longstanding protection against CT- or LT-induced diarrhea (for > or = 6 months after primary immunization), and a single booster immunization extended the duration of protective immunity by at least 4 months. Furthermore, MucoRice-CTB vaccination prevented diarrhea in the event of V. cholerae and LT-ETEC challenges. Thus, MucoRice-CTB is an effective long-term cold chain-free oral vaccine that induces CTB-specific SIgA-mediated longstanding protection against V. cholerae- or LT-ETEC-induced diarrhea.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Oral rice-based vaccine induces passive and active immunity against enterotoxigenic E. coli-mediated diarrhea in pigs.Vaccine. 2015 Sep 22;33(39):5204-11. doi: 10.1016/j.vaccine.2015.07.074. Epub 2015 Aug 4. Vaccine. 2015. PMID: 26254309
-
A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.J Immunol. 2009 Nov 15;183(10):6538-44. doi: 10.4049/jimmunol.0901480. Epub 2009 Oct 30. J Immunol. 2009. PMID: 19880451
-
Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.Vaccine. 2007 Dec 12;25(51):8574-84. doi: 10.1016/j.vaccine.2007.09.074. Epub 2007 Oct 26. Vaccine. 2007. PMID: 18045752
-
From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development.Indian J Med Res. 2011 Feb;133(2):188-96. Indian J Med Res. 2011. PMID: 21415493 Free PMC article. Review.
-
Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera.Expert Rev Vaccines. 2008 Jul;7(5):561-7. doi: 10.1586/14760584.7.5.561. Expert Rev Vaccines. 2008. PMID: 18564011 Review.
Cited by
-
Combination vaccines against diarrheal diseases.Hum Vaccin Immunother. 2015;11(6):1434-48. doi: 10.4161/21645515.2014.986984. Hum Vaccin Immunother. 2015. PMID: 25891647 Free PMC article. Review.
-
Quorum Sensing, Biofilm, and Intestinal Mucosal Barrier: Involvement the Role of Probiotic.Front Cell Infect Microbiol. 2020 Sep 25;10:538077. doi: 10.3389/fcimb.2020.538077. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 33102249 Free PMC article. Review.
-
Mucosal genetic immunization through microsphere-based oral carriers.Hum Vaccin Immunother. 2013 Oct;9(10):2222-7. doi: 10.4161/hv.25325. Epub 2013 Jun 11. Hum Vaccin Immunother. 2013. PMID: 24051430 Free PMC article.
-
Rotavirus vaccine efficacy: current status and areas for improvement.Hum Vaccin Immunother. 2019;15(6):1237-1250. doi: 10.1080/21645515.2018.1520583. Epub 2018 Sep 19. Hum Vaccin Immunother. 2019. PMID: 30215578 Free PMC article. Review.
-
Vaccination strategies to promote mucosal antibody responses.Immunity. 2010 Oct 29;33(4):479-91. doi: 10.1016/j.immuni.2010.09.013. Immunity. 2010. PMID: 21029959 Free PMC article. Review.
References
-
- Ryan ET, et al. Mortality, morbidity, and microbiology of endemic cholera among hospitalized patients in Dhaka, Bangladesh. Am J Trop Med Hyg. 2000;63:12–20. - PubMed
-
- Hill DR, Ford L, Lalloo DG. Oral cholera vaccines: Use in clinical practice. Lancet Infect Dis. 2006;6:361–373. - PubMed
-
- Clemens JD, et al. Field trial of oral cholera vaccines in Bangladesh. Lancet. 1986;328:124–127. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous